Literature DB >> 19457879

Group B streptococcal disease in infants: a case control study.

P T Heath1, G F Balfour, H Tighe, N Q Verlander, T L Lamagni, A Efstratiou.   

Abstract

OBJECTIVES: To describe and quantify the maternal and neonatal factors associated with Group B streptococcus (GBS) disease in infants <90 days of age.
SETTING: Neonatal Units in London, Oxford, Portsmouth and Bristol. PATIENTS: Cases were infants <90 days of age with invasive GBS disease diagnosed between 2000 and 2003, and controls were healthy infants born in the same hospital and in the same birth weight category. MAIN OUTCOME MEASURES: Demographic and clinical data on the mother, baby, birth and neonatal stay.
RESULTS: 138 cases and 305 controls were recruited. The majority of cases (74%) presented in the first week of life (early onset, EO); most on day 1 (89%). 65% of EO cases had one or more clinical risk factors (prematurity, prolonged rupture of membranes (PROM), known maternal GBS carriage, fever during labour). A multivariable logistic regression analysis found that the strongest independent associations with GBS disease were known maternal carriage of GBS (odds ratio (OR) 6.9), maternal infection in the peripartum period (OR 4.2) and maximum temperature in labour (OR 2.2 per degrees C). GBS disease was associated with twice the likelihood of PROM and fetal tachycardia (p = 0.05 and 0.07 respectively). EO cases had lower Apgar scores and were more likely to have respiratory distress and convulsions, and to require tube feeding than controls. They spent longer in hospital than controls, requiring longer stays at all levels of care.
CONCLUSIONS: Independent of birth weight, a number of maternal, birth and neonatal factors are significantly associated with GBS disease. The management of babies with GBS disease results in an appreciable use of hospital resources.

Entities:  

Mesh:

Year:  2009        PMID: 19457879     DOI: 10.1136/adc.2008.148874

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  7 in total

1.  Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study.

Authors:  Clara Carreras-Abad; Madeleine Cochet; Tom Hall; Laxmee Ramkhelawon; Asma Khalil; Elisabeth Peregrine; Latha Vinayakarao; Sharmila Sivarajan; Rosol Hamid; Tim Planche; Elizabeth Sheridan; Stephen Winchester; Jane Plumb; Abdelmajid Djennad; Nick Andrews; Kirsty Le Doare; Paul Heath
Journal:  Health Technol Assess       Date:  2019-12       Impact factor: 4.014

Review 2.  Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.

Authors:  Miwako Kobayashi; Johan Vekemans; Carol J Baker; Adam J Ratner; Kirsty Le Doare; Stephanie J Schrag
Journal:  F1000Res       Date:  2016-09-22

3.  Distribution of Pilus island and antibiotic resistance genes in Streptococcus agalactiae obtained from vagina of pregnant women in Yazd, Iran.

Authors:  Mahdieh Nabavinia; Mohammad Bagher Khalili; Maryam Sadeh; Gilda Eslami; Mahmood Vakili; Nastaran Azartoos; Mahdiye Mojibiyan
Journal:  Iran J Microbiol       Date:  2020-10

4.  Group B streptococcal infections in infants in Iceland: clinical and microbiological factors.

Authors:  Birta Baeringsdottir; Helga Erlendsdottir; Erla Soffia Bjornsdottir; Elisabete R Martins; Mário Ramirez; Asgeir Haraldsson; Thordur Thorkelsson
Journal:  J Med Microbiol       Date:  2021-09       Impact factor: 2.472

5.  Maternal and neonatal risk factors for early-onset group B streptococcal disease: a case control study.

Authors:  Hanan M Al-Kadri; Samira S Bamuhair; Sameera M Al Johani; Namsha A Al-Buriki; Hani M Tamim
Journal:  Int J Womens Health       Date:  2013-10-29

6.  Severe sepsis in women with group B Streptococcus in pregnancy: an exploratory UK national case-control study.

Authors:  Asli Kalin; Colleen Acosta; Jennifer J Kurinczuk; Peter Brocklehurst; Marian Knight
Journal:  BMJ Open       Date:  2015-10-08       Impact factor: 2.692

7.  Knowledge gaps among South African healthcare providers regarding the prevention of neonatal group B streptococcal disease.

Authors:  Caris A Price; Lionel Green-Thompson; Vijay G Mammen; Shabir A Madhi; Sanjay G Lala; Ziyaad Dangor
Journal:  PLoS One       Date:  2018-10-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.